HMG CoA reductase inhibitors (statins) for kidney transplant recipients-Reference-Cited by-同舟云学术

HMG CoA reductase inhibitors (statins) for kidney transplant recipients

Published:2014-01-27 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Palmer Suetonia C¹,Navaneethan Sankar D²,Craig Jonathan C³⁴,Perkovic Vlado⁵,Johnson David W⁶,Nigwekar Sagar U⁷,Hegbrant Jorgen⁸,Strippoli Giovanni FM⁴⁹¹⁰¹¹¹²

Affiliation:

1. University of Otago Christchurch; Department of Medicine; 2 Riccarton Ave PO Box 4345 Christchurch New Zealand 8140

2. Glickman Urological and Kidney Institute, Cleveland Clinic; Department of Nephrology and Hypertension; Cleveland OH USA 44195

3. The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006

4. The Children's Hospital at Westmead; Cochrane Renal Group, Centre for Kidney Research; Westmead NSW Australia 2145

5. The George Institute for International Health; Renal and Metabolic Division; Camperdown NSW Australia

6. Princess Alexandra Hospital; Department of Nephrology; Ipswich Rd Woolloongabba Queensland Australia 4102

7. Harvard Medical School; Brigham and Women's Hospital, Massachusetts General Hospital, Scholars in Clinical Sciences Program; Boston MA USA

8. Diaverum Renal Services Group; Medical Office; PO Box 4167 Lund Sweden SE-227 22

9. Mario Negri Sud Foundation; Clinical Pharmacology and Epidemiology; Santa Maria Imbaro Italy

10. Amedeo Avogadro University of Eastern Piedmont; Novara Italy

11. Diaverum; Medical Scientific Office; Lund Sweden

12. Diaverum Academy; Bari Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005019.pub4/fullpdf

Reference190 articles.

1. Cerebrovascular events in renal transplant recipients;Abedini;Transplantation,2009

2. Inflammation in renal transplantation;Abedini;Clinical Journal of the American Society of Nephrology: CJASN,2009

3. Association between body mass index (BMI) all cause mortality, renal and cardiac endpoints in renal transplant recipients in the Alert Extension Study [abstract no: 56];Abedini;American Journal of Transplantation,2009

4. Asymmetric dimethylarginine (ADMA) predicts progression to graft failure and major cardiac events in renal transplant recipients (RTR) [abstract no: F-FC149];Abedini;Journal of the American Society of Nephrology,2006

5. Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients;Abedini;Kidney International,2010

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024;BMC Nephrology;2024-07-06

2. Clinical Outcomes of Renal Transplant Recipients Undergoing Percutaneous Coronary Intervention;Heart, Lung and Circulation;2024-07

3. Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023;Atherosclerosis Plus;2024-03

4. The Seattle Heart Failure Model in Kidney Transplant Recipients;Journal of Clinical Medicine;2023-12-11

5. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29